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Consistent signatures of selection 
from genomic analysis of pairs of 
temporal and spatial Plasmodium 
falciparum populations from The 
Gambia
Alfred Amambua-Ngwa1, David Jeffries1, Roberto Amato2, Archibald Worwui1, Mane Karim1, 
Sukai Ceesay1, Haddy Nyang1, Davis Nwakanma1, Joseph Okebe1, Dominic Kwiatkowski3, 
David J. Conway  2 & Umberto D’Alessandro1,2
Genome sequences of 247 Plasmodium falciparum isolates collected in The Gambia in 2008 and 2014 
were analysed to identify changes possibly related to the scale-up of antimalarial interventions 
that occurred during this period. Overall, there were 15 regions across the genomes with signatures 
of positive selection. Five of these were sweeps around known drug resistance and antigenic loci. 
Signatures at antigenic loci such as thrombospodin related adhesive protein (Pftrap) were most 
frequent in eastern Gambia, where parasite prevalence and transmission remain high. There was a 
strong temporal differentiation at a non-synonymous SNP in a cysteine desulfarase (Pfnfs) involved in 
iron-sulphur complex biogenesis. During the 7-year period, the frequency of the lysine variant at codon 
65 (Pfnfs-Q65K) increased by 22% (10% to 32%) in the Greater Banjul area. Between 2014 and 2015, 
the frequency of this variant increased by 6% (20% to 26%) in eastern Gambia. IC50 for lumefantrine was 
significantly higher in Pfnfs-65K isolates. This is probably the first evidence of directional selection on 
Pfnfs or linked loci by lumefantrine. Given the declining malaria transmission, the consequent loss of 
population immunity, and sustained drug pressure, it is important to monitor Gambian P. falciparum 
populations for further signs of adaptation.
The success of malaria interventions such as artemisinin-based combination therapies (ACTs), seasonal malaria 
chemoprevention, long lasting insecticidal nets (LLIN) and indoor residual spraying (IRS) in reducing malaria 
burden has raised hopes for malaria elimination1,2. However, this enthusiasm is threatened by the emergence of 
artemisinin resistance (artR) in South East Asia (SEA)3, resulting into coordinated effort to limit its spread beyond 
SEA and detect any emergence in sub-Saharan Africa (sSA)4. Detailed surveillance for spatial and temporal trends 
in the frequencies of mutations associated with resistance to artemisinin and partner drugs is essential, particu-
larly for the non-synonymous single nucleotide polymorphisms (SNP) in the Kelch propeller and BTB-POZ 
domains (KPBD) of the P. falciparum gene (Pfk13, Pf3D7_1343700) that have been associated with delayed par-
asite clearance; the artemisinin resistance phenotype5. The prevalence of Pfk13 artR polymorphisms is high in 
SEA but low in sSA6,7. However, there are increasing reports that suggest reduced susceptibility of P. falciparum 
to ACTs beyond SEA, including cases of complete treatment failure in Africa8–10. These artemisinin-tolerant par-
asites may have been selected by the increased use of ACTs in the last decade. Such selection would leave genetic 
markers of adaptation in the P. falciparum population.
Population genetics approaches to identify markers of local adaptation often include comparison of genetic 
variation between spatially separated populations. In sSA, this has been demonstrated in pairwise comparisons 
of P. falciparum genomes between The Gambia and Guinea, two sites within Ghana, and across eight locations 
spanning ~1000 Km in Mauritania11–13. These studies assessed the allele frequency spectra and patterns of linkage 
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disequilibrium, allowing for the identification of signatures of differentiation and positive selection, which could 
be due to local adaptation. Isolates from these sites were mostly collected over a single transmission season and 
do not provide information on the stability of genomic structure of the populations over a longer period, during 
which changes may occur, including coverage of control interventions. Temporal analysis has helped in under-
standing the evolution of drug resistance loci14–16. In addition, candidate markers for artemisinin resistance in 
P. falciparum isolates from SEA were identified by examining SNPs with allele frequency shifts similar to the 
Pfk13-C580Y17 resistance marker. Presently, there is no reference marker for artR such as the Pfk13-C580Y for 
sSA parasites, so this approach may not be feasible. However, by comparing the genomes of isolates before and 
after the introduction of ACTs, genomic changes and signatures of sustained antimalarial drug pressure and 
decline in disease burden can be identified in settings such as The Gambia.
Between 2005 and 2015, the incidence of malaria in the Gambia dropped by over 75% following the wide-
spread use of artemether-lumefantrine (AL) and high coverage of vector control interventions, namely LLINs and 
IRS18,19. Malaria transmission in the country has become increasingly heterogeneous, with prevalence of infection 
between ~5% and >40% in the west and eastern regions respectively20. AL was introduced as first-line treatment 
in 2008, replacing Sulfadoxine-Pyrimethamine (SP), which remains in use for intermittent preventive treatment 
during pregnancy and for seasonal malaria chemoprevention (SMC), combined with amodiaquine (since 2014)21. 
Chloroquine and other antimalarial monotherapy remains available and poorly regulated, in the private and 
informal sector (personal correspondence)22.
We recently reported an increasing proportion of P. falciparum isolates with ex vivo tolerance to lumefantrine 
in western Gambia23. Resistance to SP and other quinolines remain high23, with whole genome scans of the 2008 
population showing strong signatures of selection around resistance markers of these drugs14,24,25. Building on 
this evidence, this study compared these earlier detected signatures to those of current populations. We detected 
sustained selection in genomic regions and new loci under differential selection that could have been selected for 
by drug pressure and other interventions.
Results
Temporal increase in linkage disequilibrium (LD), low complexity and spatial substructure 
between recent populations. Linkage disequilibrium between 16,629 coding SNPs was low in all three 
populations, decaying rapidly below an r2 of 0.05 within 5000 base pairs (Fig. 1). Long range LD was evident 
mainly for the 2008 and 2014 populations from Greater Banjul (GBJ), (Supplementary Fig. 1). The extent of LD 
decay correlated with parasite prevalence; being highest for the 2014 population from Basse followed by the 2008 
and then 2014 GBJ populations. Median infection complexity determined by the inverse measure of outcrossing 
(Fws) was low for all populations despite a narrow reduction in Fws values for the GBJ 2014 samples (median Fws 
from 0.91 to 0.78) compared to 2008. Median Fws for Basse was 0.83, and not significantly different from the GBJ 
2008 population. Isolates from the three populations did not form significantly distinct clusters by principal com-
ponent analysis (PCA), based on 10,862 low LD SNPs. However, dimension 1 and 2 of the PCA analysis showed 
low-level separation of the recent 2014 spatial populations from GBJ and Basse, though with significant overlap 
of the geographic clusters (Supplementary Fig. 2). There was a low genome wide fixation index (0.014, SD 0.019), 
which confirms a lack of significant structure between the spatial population pair (GBJ and Basse from 2014). The 
spatial fixation index was higher than that observed between the temporal population pair of 2008 and 2014 from 
GBJ, which was 0.009, with a standard deviation of 0.0166.
Consistent selective sweeps around drug resistance and antigenic loci in all populations. 
Regions that have undergone positive selection would show reduced heterozygosity and extended haplotypes26. 
Based on the standardised integrated haplotype score (|iHS|), we identified 1066SNPs within 11 regions of hard 
sweeps on chromosomes 1, 4, 6, 7, 8, 9, 11, 13 and 14 (Supplementary Fig. 3). There were seven consistent sweeps 
Figure 1. The decay of linkage disequilibrium (r2) with physical distance (kilobases) for coding single 
nucleotide polymorphisms in three Gambian P. falciparum populations. Each line is a smoothed fit of the 
pairwise linkage disequilibrium against distance per population; Greater Banjul 2008, 2014 and Basse 2014.
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across all populations and these included the strongest known P. falciparum sweep that spans the chloroquine 
resistance transport (Pfcrt) on chromosome 7. The only two SNPs that reached the significance threshold for |iHS| 
in the recent 2014 population from GBJ were on coding regions of conserved proteins located 60kbp from Pfcrt 
(PF3D7_0710200, PF3D7_071350). The sweep on chromosome 11 spanning Pfama1 gene was only significant 
in the GBJ 2008 population, while that spanning the Pfmsp1 and Pftrap genes on chromosomes 9 and 13, respec-
tively were the strongest in the 2014 Basse population. Other antigenic loci within sweep signatures included the 
SURFINs (1.1, 4.2 and 8.2) and merozoite surface proteins 7–like gene cluster on chromosome 13. |iHS| values are 
listed in Supplementary Tables (sheets: GBJ2008-2014_iHS, Basse_iHS).
Differences in signatures of positive selection between populations. Genomic loci with differences 
in recent selective signatures between populations were consistent for both the relative integrated extended hap-
lotype homozygosity test between populations (Rsb) and the cross population extended haplotype homozygosity 
(XP-EHH) index (Fig. 2 and Supplementary Fig. 4)27. We identified 15 genomic regions (20–220 Kb, >10 SNPs 
and Wstat score >5) with differences in the range of extended haplotypes between population pairs (Table 1). 
Five of these regions on chromosomes 4, 6, 7, 8 and 13 were significantly different in both temporal and spatial 
comparisons of extended haplotypes. The regions on chromosome 4 and 7 spanned the known sweeps in drug 
resistance associates genes- Pfdhfr and Pfcrt respectively, while that on chromosome 6 had also been previously 
characterised28. We found relatively reduced lengths and frequencies of extended haplotypes in the 2014 popu-
lations for SNPs within the following drug resistance marker codons- Pfdhfr-S108N, Pfcrt-K76T, Pfmdr1-Y184T 
and Pfdhps-S436A (Supplementary Fig. 5). The bifunctional dihydrofolate synthetase–folylpolyglutamate syn-
thetase (Pfdhfs-fpgs) located on chromosome 13 had significant differences in extended haplotype between the 
temporal population pair (identified only by Rsb), though it is not targeted by antifolate antimalarial regimes29.
Evidence of recent positive selection on antigenic loci was also supported by Rsb and XP-EHH analyses. The 
signal on chromosome 8 spanned three export proteins and the invasion associated gene, Pfclag8, while that 
on chromosome 13 was around the Pfmsp7-like cluster and Pftrap. SNPs in the Pftrap region had the highest 
|iHS| in the Basse population, indicating continuous selection on these antigenic loci. Other antigenic regions 
of differential positive selection were coding for Pfdblmsp2 and Pflsa on chromosome 10; Pfresa and Pflsap1 on 
chromosome 12, which were specifically different by Rsb between temporal population pairs (Table 1). All can-
didate genes within positive selection windows by Rsb and XP-EHH are listed in Supplementary Tables (sheet: 
Rsb_XPEHH_Top Genes).
A chromosome 5 signature of positive selection in the recent GBJ-2014 population. The widest 
genomic region with clusters of SNPs with extended haplotype differences between the pair of temporal popu-
lations spanned 220 Kb on chromosome 5. SNPs with the highest Rsb value in this region were within the cod-
ing frame of tRNA pseudouridine synthase, putative (PF3D7_0516300), downstream of the cation transporter 
Pfatpase1. Examination of the decay of haplotypes in this region showed increased frequencies of haplotypes on 
the non-reference allele in the current GBJ 2014 population (Supplementary Fig. 6). The region codes mostly for 
metabolic proteins (PlasmoDB). Three of these are involved in inositol pathways, including phosphatidylinositol 
3-kinase (Pfpi3k, PF3D7_0515300), which is linked to artemisinin resistance mechanisms30.
Allele frequency differences between temporal population pair. We found 6 SNPs significantly 
(−log10Pvalue ≥ 5) differentiating by population fixation index (FST) between our temporal population pair 
Figure 2. Manhattan plots of −log10 of p-values from the distribution of XP-EHH cross population test for 
positive selection at genome wide polymorphic coding SNP loci in P. falciparum populations from The Gambia. 
(a) XP-EHH derived from pairwise comparison of Greater Banjul 2008 against 2014 isolates. (b) XP-EHH 
derived from comparing 2014 population from Greater Banjul with that from Basse. Regions with SNP loci 
above a set significance threshold (p = <10−5) are marked with an asterisk.
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on chromosomes 7, 13 and 14 (Fig. 3a). The strongest evidence of temporal differentiation was observed for a 
non-synonymous SNP (ns-SNP) on a metabolic gene, cysteine desulfurase (Pfnfs, PF3D7_0727200), which had 
three ns-SNPs with high FST values. Sliding window analysis of FST values located a 27kbp haplotype around Pfnfs 
on chromosome 7 with significant differences in frequencies between the temporal population pair (Table 2 and 
Supplementary Fig. 6). SNPs in two genes upstream Pfnfs; mitochondrial import inner membrane translocase 
subunit TIM50, putative (Pftim50, PF3D7_0726900) and vacuolar protein sorting-associated protein 53, putative 
(Pfvpsa53, PF3D7_0727000) were also identified as outliers by the extended Lewontin and Krakauer (LK) test, 
FLK, between temporal populations (Supplementary Fig. 7a). The widest region with a cluster of differentiating 
SNPs between these populations was the 220 kbp selective signature identified by Rsb on chromosome 5 (Table 2). 
We further showed by hapFLK that haplotype frequencies around tRNA pseudouridine synthase within this chro-
mosome 5 region differ between our temporal population pair from GBJ (Supplementary Fig. 7b). Differences in 
haplotype frequencies on the tRNA pseudouridine synthase on chromosome 5 and cysteine desulfarase in chro-
mosome 7 were more significant between temporal population pair from the GBJ region. Other top hapFLK out-
liers included Pfclag2 on chromosome 2 and an exported protein Pfphistb next to Pfsurfin14.1 on chromosome 14. 
These results confirm differences in the sweep signatures detected in these regions by Rsb and XP-EHH between 
the temporal population pair. The chromosome 5 region is ~200 kbp upstream of the known Pfmdr1 sweep on 
chromosome 5, which was not detected by our genome scan.
Allele frequency differences between spatial population pair. In line with the higher genome-wide 
fixation index between the spatial population pair, more SNPs (20) were significantly differentiating between GBJ 
and Basse isolates collected in 2014 (Fig. 3b). Half of these were located on chromosome 7, spanning the region 
coding for the chloroquine resistance gene (Pfcrt), (Supplementary Fig. 7c). However, the strongest indication of 
spatial differentiation by FST was on a s-SNP in the antigenic gene, rhoptry-associated membrane antigen (Pframa, 
PF3D7_0707300). High FST at ns-SNPs clustered within the coding frame of a conserved protein of unknown 
function (PF3D7_0710200), which has homologous domains with reticulocyte binding protein 1 (Pfrh1). This 
gene had significant FST values for 5 ns-SNPs and 1 s-SNP. The widest window of SNPs with high FST values 
between the spatial population pair was on chromosome 4, spanning the drug resistance locus Pfdhfr, which also 
showed sweep differences detected by Rsb and XP-EHH between the spatial population pair. SNPs around Pfdhfr 
were within 0.01% of top hits for haplotype frequency differences between spatial populations determined by spa-
tial hapFLK (Supplementary Fig. 7d). Differential selection on haplotypes in the autophagy-related relate protein 
(Pfatg7, PF3D7_1126100) on chromosome 11 was specifically detected by hapFLK between spatial population 
pair. Evidence of differentiation on haplotypes common to both temporal and spatial comparisons population 
pairs were seen on Pfclag2 on chromosome 2, Pfset1 on chromosome 6 and Pfsurfin14.1 on chromosome 14. 
Indices of differentiation for SNPs are listed in Supplementary Tables file (sheets: FLK_Temporal, FLK_Spatial 
hapflk_temporal, hapflk_Spatial).
Directional selection of Plasmodium falciparum cysteine desulfarase variant in GBJ populations. 
We determined changes in frequencies of alleles at Pf3D7_07_v3:1158217 within cysteine desulfarase (Pfnfs) 
CHR
Start 
(kbp)
Stop 
(kbp)
Size 
(kbp) SNPs (n)
Wtemp 
Rsb
Wtemp XP-
EHH Wspatial Rsb
Wspatial XP-
EHH Gene IDs within window
3 350 390 40 46 6.2 6.3 PF3D7_0307900–0309200
3 530 570 40 20 5.3 PF3D7_0312500–0314100
4 630 810 180 162 9 17.4 20.3 21.9 PF3D7_0414000–0418000*
5 470 690 220 228 5.4 12.3 PF3D7_0511200–0516600
6 1230 1270 20 15 10.3 12.5 19.2 12.4 PF3D7_0629700–0630300*
7 350 530 180 193 7 13.9 49.4 68.3 PF3D7_0707500–0712000*
7 570 690 120 117 13 23 23.3 PF3D7_0712600–0715500*
8 1350 1370 20 30 8.2 11.7 5.5 PF3D7_0831500–0831700*
9 210 290 80 69 7.6 5.7 PF3D7_0904500–0905800
10 1430 1490 60 48 5.5 PF3D7_1036300–1037500
11 210 290 80 51 5.8 6.5 PF3D7_1104900–1106900
12 62 110 47.9 66 8.7 PF3D7_1200700–1202000
13 1030 1070 40 17 5.4 PF3D7_1324600–325700
13 1450 1530 80 94 8.1 6 5.4 PF3D7_1335400–1337800*
13 2110 2130 20 29 11.4 PF3D7_1352700–1353100
Table 1. Top windows of significant differences in signatures of positive selection. Candidate regions were 
defined when at least 10 SNPs within a 20kbp window had significant differences in extended haplotype 
homozygosity measured by cross population indices Rsb and XP-EHH between the temporal population pair 
from Greater Banjul (2008 versus 2014) and the spatial pair (2014 Greater Banjul and Basse populations). 
Physical windows (kbp)with a Wstat threshold from GenWin spline analysis between temporal and spatial pairs 
are represented as Wtemp and Wspatial respectively for each index. Rows with common windows between temporal 
and spatial pair comparisons are marked with * in the last column. The first column presents the chromosome 
number (CHR).
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gene in 521 P. falciparum isolates collected yearly between 2008 and 2015. The reference allele at this locus codes 
for the polar charged amino acid, lysine (K) at codon 65 of Pfnfs. The alternative allele codes for the polar but 
uncharged amino acid, glutamine (Q). Allelic discrimination analysis of temporally collected isolates spanning 
this period from GBJ showed a steady increase in the frequency of the reference type allele of the Pfnfs SNP from 
2010 (Fig. 4a). The Pfnfs-65K reference allele was present in 10% of clinical malaria samples from the GBJ region, 
at the time of introduction of ACTs in 2008 in the country. Its frequency dropped slightly to 7% by 2010 and 
then rose steadily to 32% of isolates by 2015. About 5–10% of isolates from mixed infections had both alleles. To 
explore if alleles at the Pfnfs locus have any association with drug responses, we analysed their distribution in iso-
lates tested in vitro for susceptibility to lumefantrine in 201523. We found significantly higher IC50 concentrations 
for lumefantrine in P. falciparum isolates from GBJ with the reference lysine variant at Pfnfs locus (p = 0.0029), 
(Fig. 4b). We found lower frequencies of this variant in clinical isolates collected in 2014 and 2015 from the higher 
transmission region of Basse. However, the reference allele frequency also increased by 6% (from 20% to 26%) 
within one year in the Basse population. Allele frequencies at SNP-1,115,521 on chromosome 8 within HECT-like 
E3 ubiquitin ligase, putative (PF3D7_0826100) were similar for the 2008 and 2015 GBJ populations.
Discussion
Plasmodium falciparum is under intense pressure from malaria control interventions across Africa and this could 
result in adaptation in some populations31. To identify regions of P. falciparum genome with recent signatures of 
Figure 3. Manhattan plots the −log10 of p-values for pairwise index of fixation FST per coding SNP between 
temporal (Greater Banjul 2008 versus 2014) and spatial (Greater Banjul 2014 versus Basse in 2014) P. falciparum 
population pairs from The Gambia; (a) Weir and Cockerham’s FST between temporal populations and (b) FST 
between spatial populations. SNP loci with indices above the threshold of significance (p = <10−5) are marked 
with an asterisk.
CHR
Start 
(kbp)
Stop 
(kbp)
Size 
(kbp)
SNPs 
(n)
Wtemp 
FST
Wspatial 
FST Gene IDs within window
2 828.7 860.9 32.2 94 4.7 11.34 PF3D7_0220600–PF3D7_0221400
4 630.1 762.3 132.2 32 4.53 5.75 PF3D7_0414000–PF3D7_0417400
5 637.9 786.9 149 94 5.18 1.92 PF3D7_0515400–PF3D7_0518900
6 1207.9 1242.1 34.2 18 5 3.17 PF3D7_0629400–PF3D7_0629700
7 388.1 437.9 49.8 74 2.61 5 PF3D7_0708500–PF3D7_0709800
7 1140.3 1167.3 27 35 7.27 1.23 PF3D7_0726600–PF3D7_0727500
11 938.5 1058.7 120.2 78 1.45 5 PF3D7_1123700–PF3D7_1127000
13 238.3 380.7 142.4 109 6.24 0.25 PF3D7_1304600–PF3D7_1308400
Table 2. Genomic windows of significant differentiation between temporal (Greater Banjul 2008 versus 2014) 
and spatial (Greater Banjul against Basse from 2014) P. falciparum population pairs. Windows, in kilobase pairs 
(kbp), with more than 10 SNPs and Wstat threshold of at least 5 (bolded fonts) from GenWin spline analysis 
of FST values were considered significant and shown as Wtemp and Wspatial for temporal and spatial FST values 
respectively. The first column presents the chromosome number (CHR).
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selection, we compared the genomes of recently collected isolates to those collected in 2008, prior to the introduc-
tion of ACTs32. We also compared genomes across a gradient of transmission intensity to detect common selective 
signatures in the more recent populations as well as local signatures that could suggest an effect of variance in 
intervention, transmission or host characteristics between sites33,34. The population pairs analysed showed no 
significant structure, as expected for African populations. This indicates sustained genetic diversity within The 
Gambian GBJ population and significant mixing of parasites between GBJ and Basse, despite the 6-years between 
sampling, intense interventions and spatial separation of 350 km across the country.
Differentiation between the GBJ temporal population pair was most evident at a cysteine desulfarase gene 
(Pfnfs). Cysteine desulfarases are involved in the delivery of sulphur to multiple metabolic pathways, including 
Fe-S complex biogenesis35. Fe-S cluster-containing proteins in apicomplexans are modulated during stress condi-
tions, drug resistance and cell development36,37. They play vital roles in housekeeping, gene expression and other 
cellular processes and are targeted by antimalarial drugs38,39. Moreover, iron homeostasis is essential for erythro-
cytic development and is implicated in drug mechanisms of quinolines40,41, same drug family like Lumefantrine. 
We therefore selected the SNP within the Pfnfs for an initial analysis of temporal changes in allele frequency. 
The frequency of the reference and minor lysine variant in Pfnfs-codon K65Q increased steadily in the GBJ 
population, two years after the introduction of ACTs in the country. Low transmission intensity and lower recom-
bination in the GBJ population will favour directional selection of this allele if it confers a selective advantage. 
Coupled to our recent report of temporal increase in the IC50s to Lumefantrine in the GBJ Gambian population23, 
it is plausible that Pfnfs may be under selection from Lumefantrine. We believe this is imposed by ACTs as the 
IC50s to Lumefantrine for isolates carrying the lysine allele were higher in the recent GBJ population. Moreover, 
the increase in the lysine allele frequencies in Basse, further suggest a common driver; such as ACTs, in both pop-
ulations. Determining if the driver of selection is at linked sites in Pftim50 and Pfvps53, or any of the other 7 genes 
within the window of differentiation could identify associated markers for Lumefantrine sensitivity monitoring. 
Tim50 proteins are involved in protein complex formation and trafficking across membranes42, while vps53 is a 
component of the heterotetrameric tethering factor named Golgi-associated retrograde protein (GARP)43. We 
are currently exploring these signatures in other regions of Africa with extensive Artemether-Lumefantrine use.
We found a region of extended haplotype difference between temporal populations on chromosome 5. High 
FST, FLK and hapFLK indices for SNPs within this window further suggest recent directional positive selec-
tion on loci in this region in the GBJ 2014 population. This is the first record of a signature of selection in this 
region in a recent P. falciparum population in sSA. The region codes for several metabolic proteins including 
Phosphatidylinositol 3-kinase, which is associated with artemisinin resistance30. The candidate SNPs in the region 
differentiating between temporal populations were on a tRNA pseudouridine synthase, responsible for the most 
abundant post-transcriptional modification of cellular RNAs44. Further analysis of this candidate region of tem-
poral differentiation for functional association with ACT tolerance is important to determine if the genes coded 
for are associated with the same mechanisms mediating artemisinin resistance in SEA.
Most of the SNPs differing in frequency between the GBJ and Basse spatial populations where around the 
drug resistance genes, Pfcrt and Pfdhfr, suggesting differences in selective pressure from Chloroquine and SP 
between the sites. However, the strongest differentiating SNPs between the populations were on antigenic loci; 
Pframa by FST and Pftrap by differences in extended haplotype. Pframa is a GPI-anchored rhoptry protein impli-
cated in merozoite invasion of erythrocytes while Pftrap mediates gliding motility and invasion processes of 
malarial sporozoites into vertebrate’s hepatocyte and mosquito’s salivary gland45–47. Selection may be imposed by 
differences in human population but with increased interventions against the vector, Pftrap could also be under 
Figure 4. Prevalence of variant alleles at position 1,158,217 of chromosome 7, in the cysteine desulfarase (NFS; 
Pf3D7_0727200) in clinical Plasmodium falciparum isolates from the Gambia; (a) the proportions of alleles 
in isolates from clinical malaria samples collected from Greater Banjul between 2008 and 2015. (b) Scatter 
plot of the lumefantrine IC50 concentrations for isolates with Pfnfs-65K (reference type) or Pfnfs-65Q (non-
reference) allele.
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selection by the differences in vector populations between coastal GBJ and inland Basse48. Though immune selec-
tion often results in balancing selection, we identified signatures of recent positive selection on multiple antigenic 
loci; Pfclag2, Pfama1, Pfmsp1, Pfdblmsp2, Pfresa, Pflsa, Pfsurfins and the Pfmsp7-like cluster. Signatures of posi-
tive selection on antigenic loci have been identified before in P. falciparum population genome scans49–51. Some 
of these antigenic loci are implicated in invasion mechanisms and new alleles that are occasionally introduced 
in a population by mutation or immigration would increase in frequency together with nearby variants before 
being checked by acquired immunity. These signatures were most significant in the Basse population, where 
exposure and immune selection could be stronger due to the relatively higher malaria transmission. Plasmodium 
falciparum enhances its invasion and immune evasion capacities to meet the environmental stressors, including 
immunity and drugs within a specific spatial or temporal population. Hence antigen haplotypes enabling fit-
ness in the immune environment would be positively selected. Some of this complex selection pattern could be 
because of heterogeneity or restriction in recombination rates between allelic variants within a gene52.
Selective sweeps around drug resistance loci, Pfdhfr, Pfcrt and the extensive region on chromosome 6 that 
coded for Pfptps and Pfmthfd, were common across all populations analysed. This result is consistent with pre-
vious genome scans of West African populations13,14,32,53. The extent of extended haplotypes around drug resist-
ance Pfcrt and Pfdhfr had reduced in recent GBJ population but remained strong in the Basse area with higher 
transmission. It is anticipated that a decay of selective sweeps would follow the withdrawal of Chloroquine and 
antifolates as first line treatment for malaria. However, the use of non-ACTs in rural areas such as Basse may be 
responsible for maintaining selective pressure on Pfcrt and Pfdhfr. Basse had a lower genome-wide LD than the 
GBJ population, where LD had increased between the 6 years of sampling. Higher LD in GBJ could be due to 
increased levels of self-fertilisation as infection prevalence and malaria transmission declined during this period. 
Higher LD and lower infection complexity has been reported in the Southeast Asian P. falciparum popula-
tions53,54, the epicentre of antimalarial resistance development and rapid evolution of selective sweeps. Hence, the 
increasing LD in GBJ and relatively lower infection complexities could favour sweeps around de novo or standing 
genetic variants associated with drug resistance, threatening the efficacy of antimalarials.
Conclusion
Plasmodium falciparum has a relatively short generation time and stochastic shifts in allele frequencies can occur 
rapidly as interventions reduce parasite populations. However, allele frequency shifts and extended haplotypes 
in genes implicated in pathways of adaptation can indicate a process to cope with environmental stress due to 
interventions. Known genomic signatures of positive selection persist in the Gambian P. falciparum population 
and a new extended region has been identified on chromosome 5. We found evidence of directional selection in 
a P. falciparum cysteine desulfarase, occurring just 6 years after introducing ACTs. Left unchecked, this could 
compromise Lumefantrine efficacy and ultimately, AL treatment failure. This is important and underlines the 
need for continuous surveillance of the role of emerging genetic variants in decreasing ACT efficacy in Africa. The 
association between Pfnfs-65k and Lumefantrine tolerance needs further evaluation in parasite populations from 
other endemic regions that rely on AL, to guide antimalarial chemotherapy policies.
Methods
Study approval. The study was reviewed and approved by MRCG scientific coordinating committee. Ethical 
approval for sample collection and for the use of the retrospective genomic data and samples from 2008–2011 
was obtained from the Gambian Government-MRCG Joint Ethics Committee. A signed informed consent was 
obtained for all participants above 18 years or from parents or guardians for those below 18 years. All sample and 
data handling methods were performed in accordance with the relevant guidelines and regulations at MRCG.
Parasite isolates. Between 2012 and 2015, patients diagnosed with uncomplicated malaria at Brikama and 
Basse health centres were invited to participate in the study. After obtaining a written informed consent, a 2 ml 
venous blood sample was collected from each participant. Brikama is a town in the Greater Banjul (GBJ) region 
on the western end, while Basse is about 350 km away on the eastern end of country. These sites reflect the gradi-
ent of transmission across the country, with low transmission in the west (5–15% parasite prevalence) and mod-
erate to high transmission in the east (15–50% parasite prevalence)20. Plasmodium falciparum isolates had been 
collected from western Gambia between 2008 and 2011 at the Royal Victoria Teaching Hospital in Banjul and the 
Brikama Health centre and stored at the Medical Research Council Unit The Gambia (MRCG) biobank. Isolates 
from 2008 had been sequenced and analysed previously for signatures of selection32.
Genome sequencing. Plasmodium falciparum parasite genomic DNA for sequencing was extracted from 
whole blood depleted of leukocytes by filtration through CF11 cellulose columns as previously described55. 
Sequencing was done on Illumina HiSeq platform in collaboration with the MalariaGEN consortium at the 
Wellcome Trust Sanger Institute, Hinxton, UK56. Paired end DNA sequence-reads (150 bp) were obtained from 
44 and 124 isolates collected in 2014 from western and eastern Gambia, respectively. Together with reads from 79 
isolates sequenced in 2008, they were aligned to the P. falciparum 3D7 reference genome (version 3) as previously 
described6,57. Nucleotide variants were called using custom in-house calling algorithms, filtering and retaining the 
dominant allele at bi-allelic coding variable sites in a genotype file. Each population was genotyped for 791,385 
high quality SNPs supported by a minimum of five short sequence reads as defined by MalariaGEN/Pf3K pipe-
line. Binary haplotype data was created denoting variable nucleotides as reference (0) or non-reference (1) allele. 
The short reads are available via the ENA database (www.ena.org).
Population complexity, structure and linkage disequilibrium. For each isolate, infection complexity 
was determined by Fws as previously described57. Pairwise SNP linkage disequilibrium (LD) expressed as the 
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coefficient of correlation (r2) between alleles at physically separated loci with a minor allele frequency (maf) of 
at least 2% across all populations was calculated in plink. A LOESS spline was fitted for r2 between loci within 
100 kbp to compare the decay in LD with physical distance in each population. To determine if there was struc-
ture between the temporal and spatial populations, all SNPs at an LD threshold (r2) < 0.5 were used to generate a 
pairwise (nxn) matrix of shared alleles between isolates, with n as isolates. The matrix was employed in principal 
component analysis, with the first and second principal components for each isolate plotted for 2008 against 2014 
GBJ populations, and for GBJ against the Basse 2014 populations.
Signatures of selection. To detect loci under recent positive selection, we calculated the extended haplo-
type homozygosity (EHH)–derived indices; standardised intra-population integrated haplotype score (|iHS|), 
and the cross-population ratio of the EHH expressed as Rsb and XP-EHH for each SNP with the R package 
REHH58. For iHS analysis, the reference and non-reference alleles were employed in lieu of the ancestral and 
derived alleles, respectively. For significance, the REHH package generates a two-sided p-value as
− − Φ − .log 10(1 2 (iHS) 0 5 ),
where Ф(iHS) represents the Gaussian cumulative distribution function. For selected significant core markers, the 
decay in haplotype frequencies in each population was examined with decay and bifurcation plots in R.
Population differentiation. Differentiation at SNP loci between population pairs were analysed using Wier 
and Cockerham’s FST per SNP, calculated with the hierfstat package in R. The variance component of FST between 
the pair of temporal and spatial populations were also determined in hierfstat. The significance of FST values were 
determined by sampling from ten million permutations of the FST distribution for each pairwise comparison. 
We minimised the false positive rate for differentiating loci by computing the extended Lewontin and Krakauer 
test, FLK, and the linked derivative hapFLK, which focuses instead on the differences of haplotype frequencies 
between populations59,60. The FLK index accounts for population size heterogeneity and possible hierarchical 
structure between populations. It computes a global FST for each SNP, but allele frequencies are first rescaled 
using a population kinship matrix, estimated from the observed genome wide data. With this rescaling, allele 
frequency differences obtained with small populations are typically down-weighted. HapFLK is an extension of 
FLK, integrating a multipoint linkage disequilibrium that regroups individual chromosomes into local haplotype 
clusters before measuring differentiation between populations59. A software for calculating FLK and HapFLK 
is free available on from (https://forge-dga.jouy.inra.fr/projects/hapflk). A p-value of 10−5 for FST and FLK was 
arbitrarily set as threshold for significance.
Outlier genomic windows of selection and differentiation. To determine genomic windows with 
contiguous significant signatures, we fitted a spline on FST, Rsb and XP-EHH values per chromosome with the 
GenWin package in R using genome-wide mean and variance values to normalise across chromosomes. GenWin 
defines a t-test like statistic, W, generated such that:
µ
=
−W x
s n( / )2
where x is the mean value over the window, μ is the mean value over the entire dataset, s2 is the sample variance of 
index across the genome, and n is the number of observations (i.e. markers) in the window61. Windows of 5000 to 
25000 bp were assessed and overlapping segments with a W value > =5, with more than 10 SNPs were considered 
significant. Functional annotations for genes within significant windows were obtained from a combination of 
tools defining gene ontologies in PlasmoDB, PANTHER, DAVID, LAMP and gene ontology tools (http://gene-
ontology.org/page/go-enrichment-analysis).
Temporal changes in allele frequency. The non-synonymous SNP at physical position 1,158,217 of 
chromosome 7 within the P. falciparum cysteine desulfarase gene (PF3D7_0727200) had the most significant 
temporal difference in allele frequency. We designed Taqman allelic discrimination assay for this polymorphism 
using the online assay design tool provided by life technologies (Life Technologies assay ID: AN7DRNA). We 
also designed an assay for a randomly chosen SNP at position 1,115,521 on chromosome 8 within HECT-like E3 
ubiquitin ligase, putative (PF3D7_0826100), (Life Technologies assay ID: ANRWF4A). We genotyped these loci 
in 521 P. falciparum isolates from GBJ region collected in 2008 (53), 2010 (68), 2012 (57), 2013 (42), 2014 (35) 
and 2015 (125); and from Basse (eastern region) in 2014 (60) and 2015 (81). Furthermore, we determined the 
difference in Lumefantrine IC50 values for isolates with the reference or non-reference allele for 61 isolates assayed 
from the 2015 GBJ population. Mann Whitney t-test was used to determine the significance of the difference in 
mean IC50s between allele-groups with a significance level set at 0.05.
Data availability. Short sequence reads analysed are available via European Nucleotide Archive.
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